Literature DB >> 32700327

Acquired haemophilia A after alemtuzumab therapy.

Marieke van der Zwan1,2, Frank W G Leebeek3, Yorick Sandberg4, Marieke J H A Kruip3, Dennis A Hesselink1,2.   

Abstract

Entities:  

Year:  2020        PMID： 32700327     DOI： 10.1111/hae.14107

Source DB:  PubMed          Journal:  Haemophilia        ISSN： 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  2 in total

1.  Clinical and Molecular Profiling to Develop a Potential Prediction Model for the Response to Alemtuzumab Therapy for Acute Kidney Transplant Rejection.

Authors:  Daphne M Hullegie-Peelen; Marieke van der Zwan; Marian C Clahsen-van Groningen; Dana A M Mustafa; Sara J Baart; Marlies E J Reinders; Carla C Baan; Dennis A Hesselink
Journal:  Clin Pharmacol Ther       Date:  2022-03-08       Impact factor: 6.903

Review 2.  New Developments in Diagnosis and Management of Acquired Hemophilia and Acquired von Willebrand Syndrome.

Authors:  Frank W G Leebeek
Journal:  Hemasphere       Date:  2021-06-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.